Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Figure S1 from The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial
  1. Home
  2. Publications
  3. Supplementary Figure S1 from The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

Supplementary Figure S1 from The Oral PI3Kδ Inhibitor Linperlisib for the Treatment of Relapsed and/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Clinical Trial

Authors:
  • TWTingyu Wang
    Tingyu Wang
  • XSXiuhua Sun
    Xiuhua Sun
  • LQLihua Qiu
    Lihua Qiu
  • HSHang Su
    Hang Su
  • JCJunning Cao
    Junning Cao
  • ZLZhiming Li
    Zhiming Li
  • YSYuqin Song
    Yuqin Song
  • LZLi Zhang
    Li Zhang
  • DLDengju Li
    Dengju Li
  • HWHuijing Wu
    Huijing Wu
  • WZWei Zhang
    Wei Zhang
  • JLJunmin Li
    Junmin Li

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707963
Abstract
Subgroup analysis of (A) ORR, (B) DOR and (C) PFS confirmed by investigator
Keywords
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • DRUG TARGETS
  • PROTEIN KINASE & PHOSPHATASE DRUG TARGETS
  • HEMATOLOGICAL CANCERS
  • LYMPHOMAS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.